Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Hemostatic effectiveness of Fibrin pad after partial nephrectomy in swine.

Hutchinson RW, Broughton D, Barbolt TA, Poandl T, Muench T, Rockar R, Johnson M, Hart J.

J Surg Res. 2011 May 15;167(2):e291-8. doi: 10.1016/j.jss.2010.01.022. Epub 2010 Feb 20.

PMID:
20451926
2.

Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.

Matonick JP, Hammond J.

J Invest Surg. 2014 Dec;27(6):360-5. doi: 10.3109/08941939.2014.941444.

PMID:
25361019
3.

Clinical applications of fibrin sealants.

Fattahi T, Mohan M, Caldwell GT.

J Oral Maxillofac Surg. 2004 Feb;62(2):218-24. Review. No abstract available.

PMID:
14762755
4.

Hemostatic effect of new surgical glue in animal partial nephrectomy models.

Naitoh Y, Kawauchi A, Kamoi K, Soh J, Okihara K, Hyon SH, Miki T.

Urology. 2013 May;81(5):1095-100. doi: 10.1016/j.urology.2013.01.002. Epub 2013 Feb 20.

PMID:
23434093
5.

Society for the Advancement of Blood Management study shows advantages of fibrin sealant over manual compression.

Zoegall S.

J Vasc Nurs. 2008 Mar;26(1):5; discussion 5. doi: 10.1016/j.jvn.2007.10.002. No abstract available.

PMID:
18295160
6.

Combination of a liquid fibrin sealant with sheet-type hemostatic agents: experimental evaluation in partial nephrectomy animal model.

Ishii K, Kawashima H, Hayama T, Asai T, Kamikawa S, Sakamoto W, Miyabashira S, Oka S, Sugimoto T.

Int J Urol. 2011 Jun;18(6):478-82. doi: 10.1111/j.1442-2042.2011.02767.x. Epub 2011 Apr 13.

7.

Comparison of a new fibrin sealant with standard topical hemostatic agents.

Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, Colonna JO 2nd, Heaton N, Mirza D, Adams R, Rees M, Lloyd D.

Arch Surg. 2004 Nov;139(11):1148-54.

PMID:
15545559
8.

A comparison of fibrin sealants in relation to their in vitro and in vivo properties.

Dickneite G, Metzner H, Pfeifer T, Kroez M, Witzke G.

Thromb Res. 2003;112(1-2):73-82.

PMID:
15013277
9.

A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery.

Fischer CP, Bochicchio G, Shen J, Patel B, Batiller J, Hart JC.

J Am Coll Surg. 2013 Sep;217(3):385-93. doi: 10.1016/j.jamcollsurg.2013.02.036.

PMID:
23969113
10.

A combination of hemostatic agents may safely replace deep medullary suture during laparoscopic partial nephrectomy in a pig model.

Ploussard G, Haddad R, Loutochin O, Bera R, Cabrera T, Malibari N, Scarlata E, Derbekyan V, Bladou F, Anidjar M.

J Urol. 2015 Jan;193(1):318-24. doi: 10.1016/j.juro.2014.07.009. Epub 2014 Jul 18.

PMID:
25046623
11.

Safety and hemostatic efficacy of fibrin pad in partial nephrectomy: results of an open-label phase I and a randomized, standard-of-care-controlled phase I/II study.

Nativ O, Patel B, Shen J, Batiller J, Horn S, Hart JC.

BMC Nephrol. 2012 Nov 8;13:147. doi: 10.1186/1471-2369-13-147.

12.

Evaluation of a novel hemostatic device in an ovine parenchymal organ bleeding model of normal and impaired hemostasis.

Turner AS, Parker D, Egbert B, Maroney M, Armstrong R, Powers N.

J Biomed Mater Res. 2002;63(1):37-47.

PMID:
11787027
13.

Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.

Lowe J, Luber J, Levitsky S, Hantak E, Montgomery J, Schiestl N, Schofield N, Marra S; TISSEEL Clinical Study Group.

J Cardiovasc Surg (Torino). 2007 Jun;48(3):323-31.

PMID:
17505437
14.

Management of surgical hemostasis: topical agents.

Sileshi B, Achneck HE, Lawson JH.

Vascular. 2008 Mar-Apr;16 Suppl 1:S22-8. Review. Erratum in: Vascular. 2009 May-Jun;17(3):181.

PMID:
18544302
15.

Comparison of poly-N-acetyl glucosamine (P-GlcNAc) with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage.

Chan MW, Schwaitzberg SD, Demcheva M, Vournakis J, Finkielsztein S, Connolly RJ.

J Trauma. 2000 Mar;48(3):454-7; discussion 457-8.

PMID:
10744283
16.

Safety and efficacy of a novel, dry powder fibrin sealant for hemostasis in hepatic resection.

Ruitenbeek K, Ayez N, Verhoef C, de Wilt JH, Bottema J, Rijken AM, van Rij M, Koopman J, Zuckerman LA, Frohna P, Porte RJ.

Dig Surg. 2014;31(6):422-7. doi: 10.1159/000370006. Epub 2015 Jan 14.

PMID:
25592001
17.

[Hemostatic effect of a novel sheeted fibrin adhesive agent, TO-193, on experimental incision models].

Ueda N, Maekawa Y, Ohtani H, Uchiyama H, Kashiwabara S, Koshiyama Y, Oda M, Kurumi M.

Nihon Yakurigaku Zasshi. 1999 Mar;113(3):177-84. Japanese.

PMID:
10347842
18.

A comparison of antifibrinolytic agents used in hemostatic fibrin sealants.

Busuttil RW.

J Am Coll Surg. 2003 Dec;197(6):1021-8. Review. No abstract available.

PMID:
14644291
19.

Comparative study of the efficacy of the common topical hemostatic agents with fibrin sealant in a rabbit aortic anastomosis model.

Kheirabadi BS, Field-Ridley A, Pearson R, MacPhee M, Drohan W, Tuthill D.

J Surg Res. 2002 Jul;106(1):99-107.

PMID:
12127814
20.

Bovine thrombin: history, use, and risk in the surgical patient.

Diesen DL, Lawson JH.

Vascular. 2008 Mar-Apr;16 Suppl 1:S29-36. Review. Erratum in: Vascular. 2009 May-Jun;17(3):181.

PMID:
18544303

Supplemental Content

Support Center